Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2020-07-14 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2020年半年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a '2020年半年度业绩预告' which translates to '2020 Half-Year Performance Forecast'. It provides estimated financial results for the period January 1, 2020 to June 30, 2020, including expected net profit growth and explanations for performance changes. It explicitly states that the financial data is preliminary and unaudited, and that detailed financial data will be disclosed in the company's '2020 Half-Year Report'. The document is relatively short (1159 characters) and serves as a performance forecast rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only, not a full interim report. Therefore, the correct classification is Earnings Release (ER).
2020-07-14 Chinese
关于向不特定对象发行可转换公司债券申请获得深圳证券交易所受理的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from the company SanNuo Biological Sensor Co., Ltd. regarding the acceptance of its application by the Shenzhen Stock Exchange for the issuance of convertible bonds to unspecified investors. It mentions regulatory review steps and the need for further approvals before implementation. The document is short (628 characters) and serves as a notification of a capital raising process rather than a detailed financial report or full financing update. It does not contain actual financial statements or detailed analysis but is an update on a financing activity. Therefore, it fits best under Capital/Financing Update (CAP).
2020-07-03 Chinese
创业板公开发行可转换公司债券募集说明书（申报稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集说明书（申报稿）" which translates to "Prospectus (Filing Draft)" for a convertible bond issuance on the Growth Enterprise Market (创业板). It contains detailed information about the bond issuance, including credit rating, risk factors, profit distribution policies, investment projects, financial data, management analysis, and legal statements. The document is comprehensive and lengthy (15,000 characters), indicating it is the actual prospectus/report rather than a brief announcement. This type of document is a capital/financing update related to fundraising activities and capital structure changes. It is not an annual report, earnings release, or other report types. Therefore, the correct classification is Capital/Financing Update (CAP).
2020-07-03 Chinese
中信证券股份有限公司关于公司公开发行可转换公司债券之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is a detailed listing sponsorship letter (上市保荐书) issued by CITIC Securities for Sinocare Inc. regarding the public issuance of convertible corporate bonds (可转换公司债券) and their listing on the Shenzhen Stock Exchange. It includes extensive company background, business overview, core technologies, financial data, risk factors, and detailed terms of the convertible bond issuance such as bond type, issuance scale, bond term, interest rate, conversion price, and adjustment mechanisms. The document is not a typical annual or interim financial report but a regulatory filing related to a capital market transaction (bond issuance and listing). It is a comprehensive regulatory disclosure document required for the bond issuance and listing process, containing detailed information about the issuer and the bond terms. This type of document fits best under the category of Capital/Financing Update (CAP), as it provides updates on the company's financing activities and capital structure changes through the issuance of convertible bonds.
2020-07-03 Chinese
关于控股股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company SanNuo Bio-Sensing Co., Ltd. regarding the release of pledge on shares held by the controlling shareholder Li Shaobo. It details the number of shares released from pledge, the proportion of shares pledged and released, and reassures about the credit status and risk control of the pledged shares. There is no financial data, no report or presentation attached, and the document is short (1123 characters). It is a regulatory announcement about share pledge status, which fits best under the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Share Issue/Capital Change or Director's Dealing, since it concerns pledge release rather than share transactions or capital changes.
2020-07-03 Chinese
中信证券股份有限公司关于公司公开发行可转换公司债券之发行保荐书
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行保荐书" (Issuance Sponsorship Letter) by 中信证券股份有限公司 (CITIC Securities Co., Ltd.) regarding the public issuance of convertible corporate bonds by 三诺生物传感股份有限公司 (Sinocare Inc.). It contains detailed sections about the issuance, the sponsor's responsibilities, legal and regulatory compliance, financial data, and risk disclosures related to the convertible bond issuance. The document is a formal sponsorship letter for a capital market transaction, specifically a convertible bond issuance, which is a financing activity. It is not an annual or quarterly report, audit report, or earnings release. It is not a simple announcement or a proxy statement. The content focuses on the capital raising process and regulatory compliance for the convertible bond issuance. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the full sponsorship letter, not just an announcement or summary.
2020-07-03 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.